Home › Funds › Tanager Wealth Management LLP › CADL

Tanager Wealth Management LLP position in CADL

CANDEL THERAPEUTICS INC · Health Care

Tanager Wealth Management LLP reported holding 198,175 shares of CADL (CANDEL THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$2.1M, representing 0.17% of its reported portfolio and ranking #46 among its reported holdings. Tanager Wealth Management LLP has disclosed CADL holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)198.18K sh
Reported value held$2.07M
Portfolio Weight0.17%
First reportedQ2 2025
Last changeHold
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How Tanager Wealth Management LLP's CADL position evolved

Tanager Wealth Management LLP first disclosed a stake in CADL in Q2 2025 at 196,631 shares (US$995K). The position peaked in Q3 2026 at 198,175 shares, worth US$2.1M. Across 6 filings, Tanager Wealth Management LLP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 198,175 shares valued at US$2.1M.

Quarter by quarter

QuarterSharesValueChange
Q2 2025 196.63K $994.95K New
Q3 2025 198.18K $1.01M Add
Q4 2025 198.18K $1.12M Hold
Q1 2026 198.18K $971.06K Hold
Q2 2026 198.18K $2.04M Hold
Q3 2026 198.18K $2.07M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CADL and 13F data

CADL (CANDEL THERAPEUTICS INC) is a Health Care company. 83 other funds we track also report a position in CADL — the largest reported positions include RTW INVESTMENTS, LP (US$66.1M), ACORN CAPITAL ADVISORS, LLC (US$36.0M), Portolan Capital Management, LLC (US$36.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CADL

All CADL fund holders →

FAQ

How long has Tanager Wealth Management LLP held CADL?

Tanager Wealth Management LLP has disclosed CADL holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is Tanager Wealth Management LLP's current position in CADL?

As of Q3 2026, Tanager Wealth Management LLP holds 198.18K shares of CADL (CANDEL THERAPEUTICS INC), valued at $2.07M, representing 0.17% of its reported portfolio and ranking #46.

Has Tanager Wealth Management LLP been buying or selling CADL?

In the latest 13F filing (Q3 2026), Tanager Wealth Management LLP held unchanged its position in CADL. The position peaked in Q3 2026 at 198.18K shares.

Which other funds hold CADL?

Other major institutional holders of CADL include RTW INVESTMENTS, LP, ACORN CAPITAL ADVISORS, LLC, Portolan Capital Management, LLC, among 83 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.